Elanco

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. 

CEO
Jeffrey N. Simmons
CEOJeffrey N. Simmons
Employees
9,900
Employees9,900
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1954
Founded1954
Employees
9,900
Employees9,900

ELAN Key Statistics

Market cap
11.37B
Market cap11.37B
Price-Earnings ratio
-55.75
Price-Earnings ratio-55.75
Dividend yield
—
Dividend yield—
Average volume
4.79M
Average volume4.79M
High today
$22.84
High today$22.84
Low today
$22.35
Low today$22.35
Open price
$22.42
Open price$22.42
Volume
2.07M
Volume2.07M
52 Week high
$27.98
52 Week high$27.98
52 Week low
$19.40
52 Week low$19.40

Stock Snapshot

With a market cap of 11.37B, Elanco(ELAN) trades at $22.77. The stock has a price-to-earnings ratio of -55.75.

On 2026-10-22, Elanco(ELAN) stock traded between a low of $22.35 and a high of $22.84. Shares are currently priced at $22.77, which is +1.9% above the low and -0.3% below the high.

Elanco(ELAN) shares are trading with a volume of 2.07M, against a daily average of 4.79M.

During the past year, Elanco(ELAN) stock moved between $19.40 at its lowest and $27.98 at its peak.

During the past year, Elanco(ELAN) stock moved between $19.40 at its lowest and $27.98 at its peak.

ELAN News

TipRanks 7h
Elanco CPO Dave Kinard to retire, Jamie Preston to succeed

Elanco (ELAN) announced the appointment of Jamie Preston as executive VP and chief people officer, or CPO, effective November 3. Preston succeeds Dave Kinard, w...

Simply Wall St 11h
Elanco Stock Could Be 49% Undervalued Despite Zenrelia Growth

has delivered a sharp 154.5% return over the past three years, which naturally puts the focus on whether the current US$22.55 share price lines up with the cash...

Elanco Stock Could Be 49% Undervalued Despite Zenrelia Growth
TipRanks 2d
Elanco downgraded to Hold from Buy at Jefferies

Jefferies downgraded Elanco (ELAN) to Hold from Buy with a price target of $24, down from $31. The firm cites the company’s softer pricing environment for the d...

Analyst ratings

88%

of 17 ratings
Buy
88.2%
Hold
11.8%
Sell
0%

More ELAN News

Zacks 6d
Are Medical Stocks Lagging Aveanna Healthcare This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Aveanna Healthcare (A...

Are Medical Stocks Lagging  Aveanna Healthcare This Year?
TipRanks 6d
Elanco initiated with a Buy at Goldman Sachs

Goldman Sachs initiated coverage of Elanco (ELAN) with a Buy rating and $32 price target The company has a diversified pharmaceuticals portfolio serving both pe...

People also own

Based on the portfolios of people who own ELAN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.